Related Experiment Videos
[Enzyme-immunoassay for autoantibodies using recombinant antigens]
1Department of Internal Medicine, Juntendo University, School of Medicine.
Nihon Rinsho. Japanese Journal of Clinical Medicine
|September 1, 1995
Summary
Enzyme-immunoassay (EIA) offers sensitive autoantibody detection but struggles with native antigens. Recombinant proteins improve EIA, but conformational autoantibodies may require complementary methods like double immunodiffusion for accurate diagnosis.
Area of Science:
- Immunology
- Biochemistry
Context:
- Enzyme-immunoassay (EIA) is a sensitive method for autoantibody detection.
- Challenges exist in routine EIA use due to difficulties in preparing native autoantigens in large quantities.
Purpose:
- To evaluate the utility of EIA using recombinant proteins for diagnosing autoimmune diseases and assessing disease activity.
- To address the limitations of recombinant antigens in detecting autoantibodies that recognize conformational epitopes.
Summary:
- EIA systems utilizing recombinant proteins have been developed to overcome native autoantigen preparation challenges.
- Some autoantibodies, particularly against nuclear antigens like U1 RNP and Sm, may not react with recombinant proteins due to their reliance on conformational epitopes.
- A combined approach using double immunodiffusion and EIA is recommended for diagnosing connective tissue diseases and evaluating disease activity.
Impact:
- The study highlights the need for complementary diagnostic methods when using recombinant antigens in EIA.
- It suggests that combining EIA with double immunodiffusion can improve the accuracy of diagnosing connective tissue diseases.
- Further clarification of the clinical significance of EIA employing recombinant antigens is warranted.